+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liver Disease Drug"

Liver Diseases Therapeutics Global Market Report 2024 - Product Thumbnail Image

Liver Diseases Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2024 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
Chronic Liver Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Liver Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Liver Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Liver Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
From
From
From
From
Chronic Liver Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Liver Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Liver Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat a variety of liver diseases, including hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly used drugs include antivirals, immunosuppressants, and antifibrotics. In addition, some drugs are used to reduce the risk of liver cancer. The Liver Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Other companies include Bristol-Myers Squibb, AstraZeneca, and Roche. Show Less Read more